Prophylaxis in haemophilia B - Prevention of bleeds and FIX consumption;Prophylaxe in der Hämophilie-B-Therapie: Reduktion der Blutungsfrequenz und FIX-Verbrauch

Hamostaseologie

Volumn 30, Issue SUPPL.1, 2010, Pages 35-36

  Siegmund, B ^a   Richter, H ^a   Pollmann, H ^a  

^a Inst fur Thromb Hamostaseologie   (Germany)

Author keywords

Continuous therapy; Factor IX; Haemophilia B; Prophylaxis; Treatment on demand

Indexed keywords

BLOOD CLOTTING FACTOR 9;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; HEMOPHILIA B; HUMAN; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; FACTOR IX; HEMOPHILIA B; HEMORRHAGE; HUMANS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79952118307     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Barthels M, Oldenburg J. Gerinnungsfaktorenkonzentrate. Hämostaseologie 2008; 28: 387-399.
2. Biss TT, Chan AK, Blanchette VS et al. for the association of hemophilia clinic directors of Canada (AHCDC) and the Canadian association of nurses in hemophilia care (CANHC). The use of prophylaxis in 2663 children and adults with haemophilia. Haemophilia 2008; 14: 923-930.
3. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-544.
4. Siegmund B, Richter H, Pollmann H. Need for prophylactic treatment in adult haemophilia A patients. Transf Med Hemother 2009; 36: 283-288.
5. Van Den Berg HM, Fischer K, Van der Bom JG et al. Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies. Haemophilia 2002; 8 (suppl 2): 43-46.